You are here: Industry Insights > Covishield

News List

DCGI extends shelf life of COVISHIELD: Document, sources expresspharma
April 01, 2021
India’s drug regulator has allowed the AstraZeneca COVID-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, according to a document reviewed by Reuters.
Bhutan PM thanks Modi for gift of additional 4 00 000 doses of COVID-19 vaccine expresspharma
March 24, 2021
As part of the "Vaccine Maitri" initiative, India has supplied over 60 million doses of made-in-India COVID-19 vaccine to 72 nations.
Interval between two doses of COVISHIELD increased to 4-8 weeks expresspharma
March 23, 2021
Protection enhanced if the second dose of COVISHIELD is administered between 6-8 weeks, says NTAGI and NEGVAC.
SII gets purchase order from government for 10 crore doses of Covishield expresspharma
March 19, 2021
Serum Institute of India (SII) has received a new purchase order from the Government of India for the supply of 10-crore doses of the Oxford-AstraZeneca COVID-19 vaccine — Covishield — each dose costing Rs 157.5, including GST, according to official ...
WHO chief scientist says India exhibited capacity to innovate, manufacture vaccines expresspharma
March 03, 2021
India has shown the capacity to be a global-scale manufacturer and also an innovator when it comes to coronavirus vaccines, World Health Organization’s Chief Scientist Soumya Swaminathan said Monday.
Serum Institute of India says prioritising domestic vaccine needs expresspharma
February 22, 2021
Many low-and middle-income countries, ranging from Bangladesh to Brazil, are depending on SII’s AstraZeneca vaccine, branded COVISHIELD.
Third Phase will begin in march and covers ages 50 and above: Harsh Vardhan expresspharma
February 08, 2021
On Friday, Health Minister Harsh Vardhan said in the Lok Sabha that the third phase of the vaccination drive is likely to begin in March.
Supply order for Covishield vaccine was placed after drug regulator approved it: Govt expresspharma
February 03, 2021
As per protocol, the supply order for COVID-19 vaccines, specifying the number of vaccine doses, was placed with the manufacturer and vaccines were delivered within three days.
Local court rejects Cutis-Biotech’s trademark-violation lawsuit against SII over ‘Covishield’ expresspharma
February 01, 2021
SII had told the court that the two companies operate in different product categories and there is no scope for confusion over the trademark.
Five perish in fire at SII Pune facility, Covishield production unaffected expresspharma
January 22, 2021
No loss of Covishield production due to multiple production buildings that was kept in reserve to deal with such contingencies, informs Adar Poonawalla.

Previous page 1 2 3 4 5 Next page